All Curated Mutation Sites in EBV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in EBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
LMP-1
  
BZLF1
  
EBNA-1
  
EBNA-2
  
EBNA-3A
  
EBNA-3B/EBNA-3C
  
LMP-2A
  
LMP-2
  
EBNA-2
  
BARF1
  
BALF2
  
BXLF1
  
BPLF1
  
BcRF1
  
BFRF2
  
BILF1
  
BLLF1
  
BMRF1
  
BNRF1
  
BOLF1
  
BRRF2
  
LF1
  

Keyword: Nasopharyngeal Carcinoma-24009107
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 24009107 S229T
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
2 24009107 G252A
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
3 24009107 D266G
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
4 24009107 D282G
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
5 24009107 D293H
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
6 24009107 D293G
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
7 24009107 G212S
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
8 24009107 S309N
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
9 24009107 D317E
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
10 24009107 D317N
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
11 24009107 Q322T
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
12 24009107 Q322N
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
13 24009107 Q322D
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
14 24009107 Q322E
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
15 24009107 E328L
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
16 24009107 E328A
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
17 24009107 E328Q
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
18 24009107 G331Q
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
19 24009107 Q334R
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
20 24009107 L338P
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
21 24009107 L338S
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
22 24009107 H352N
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
23 24009107 H352S
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
24 24009107 H352R
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
25 24009107 S366T
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
26 24009107 S366A
LMP-1
LMP-1
Nasopharyngeal Carcinoma
L
View
Contents
Description

The table shows all curated mutation sites of EBV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.